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Abstract: A fluorometabolite, 5-fluoro-5-deoxy-D-ribulose (5-FDRul), from the culture broth of
the soil bacterium Streptomyces sp. MA37, was identified through a combination of genetic
manipulation, chemo-enzymatic synthesis and NMR comparison. Although 5-FDRul has been
chemically synthesized before, it was not an intermediate or a shunt product in previous studies
of fluorometalism in S. cattleya. Our study of MA37 demonstrates that 5-FDRul is a naturally
occurring fluorometabolite, rendering it a new addition to this rare collection of natural products.
The genetic inactivation of key biosynthetic genes involved in the fluorometabolisms in MA37 resulted
in the increased accumulation of unidentified fluorometabolites as observed from 19F-NMR spectral
comparison among the wild type (WT) of MA37 and the mutated variants, providing evidence of the
presence of other new biosynthetic enzymes involved in the fluorometabolite pathway in MA37.
Keywords: fluorometabolites; 5-FDRul; Streptomyces sp. MA37; genetic manipulation;
chemo-enzymatic synthesis
1. Introduction
Fluorinated compounds have remained important in the field of lead compound discovery due to
their wide therapeutic and agricultural applications [1]. The unmet need for a fluorine-incorporated
lead compound presents an unremitting impetus for the development of selectively efficient fluorination
methods. Compared to the vast amount of synthetic fluorinated compounds, naturally occurring
fluorinated natural products are extremely rare, most of which are fluorinated fatty acids with different
chain lengths discovered in sub-tropical and tropical plants [1]. Fewer than thirty fluorinated natural
products have been identified so far, including six structurally different ones of bacterial origin, such as
fluoroacetate (FAc) 1, 4-fluorothreonine (4-FT) 2 [1], 5-fluoro-2,3,4-trihydroxypentanoic acid (FHPA)
3 [2], nucleocidin 4 [3] and two new glycosylated nucleocidin derivatives (5a, 5b) (Figure 1A) [4].
Of these, 1 is a toxin that inhibits the citric acid cycle while 2 and 4 were discovered as antimicrobial
metabolites. The biological function of 3 in the producing strain remains elusive. The scarcity
of fluorinated compounds found in nature, compared to thousands of brominated or iodinated
compounds, mainly results from the high electronegativity of fluorine, which precludes the common
strategy for halogenation that involves the oxidation of fluoride ions [5]. In addition, the solvation
tendency of fluoride ions in aqueous solutions causes fluoride to need extra energy to become a good
nucleophile. Such desolvation processes elevate the difficulty of biochemically incorporating fluorine
into complex organic molecules [5].
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Figure 1. (A) Fluorometabolites discovered from bacteria so far. (B) The proposed biosynthetic 
pathways of fluoroacetate 1 and 4-fluorothreonine 2 in Streptomyces cattleya and Streptomyces sp. 
MA37, and FHPA 3 in Streptomyces sp. MA37. 
For decades, Streptomyces cattleya remained the only genetically tractable strain producing two 
fluorinated natural products, 1 and 2. The major breakthrough was the identification of the first 
fluorination enzyme, fluorinase, which converts S-adenosyl-l-methionine (SAM) 6 and fluoride ions 
to generate 5′-fluoro-5′-deoxy-adenosine (5′-FDA 7) [6,7]. Subsequent studies resulted in the 
elucidation of the biosynthetic pathway of 1 and 2 in S. cattleya as illustrated in Figure 1B [8]. Recent 
studies demonstrated that two genes, fthB and fthC, are highly conserved in the biosynthetic gene 
clusters (BGCs) that direct the production of 2 [9]. While the genetic inactivation of fthB had no 
perturbation in secreted 2 in the S. cattleya variant as observed in 19F-NMR analysis, biochemical 
analysis indicated that FthB, an aminoacyl RNA deacylase, plays an essential role in the detoxification 
of 2, by counteracting the misacylation of fluorothreonyl-tRNA which otherwise would be 
misincorporated into protein in place of L-threonine [9]. While knocking out fthC significantly 
reduced the concentration of 2 in culture broth [9], the intracellular 2 was accumulated in the S. 
cattleya variant, indicating that FthC is a 4-FT exporter. The efforts towards understanding the 
fluorination enzyme, fluorometabolisms in S. cattleya and related biotransformations have offered a 
new bio-based approach to generating high-value fluorinated chemicals [10]. 
In the last decade, advanced genome sequencing technologies have enabled the use of genome 
mining strategies to identify several other potential fluorometabolite-producing strains [2,11]. Recent 
studies revealed that Streptomyces sp. MA37 (MA37), a soil isolate, is a talented natural product 
producing strain [12–15]. In particular, MA37 produces 1, 2 and a series of unidentified fluorinated 
metabolites as observed in 19F-NMR analysis of the supernatant of the culture broth of MA37 [11]. It 
has been shown that 1 and 2 in MA37 originate from the same biosynthetic pathway as the one in S. 
cattleya [11,16]. A combination of chemical synthesis, bioinformatic analysis and biochemical assays 
allowed the discovery of 3 as a new fluorometabolite and the identification of the second fdr 
biosynthetic gene cluster (BGC) in MA37 [2]. However, the rest of the fluorometabolites observed in 
MA37 remain to be determined. 
Here we describe the identification of a naturally occurring fluorometabolite, 5-fluoro-5-deoxy-
D-ribulose (5-FDRul) 9, from the culture broth of MA37, using a combination of genetic inactivation, 
chemo-enzymatic synthesis and 19F-NMR comparison. Although reported before as chemical probes 
during the previous fluorometabolism study in S. cattleya, this is the first report indicating that 9 is a 
naturally occurring fluorinated compound. During the course of our studies, we also observed that 
the production of several fluorinated natural products was upregulated among several MA37 
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t s of fluoroacetate 1 and 4-fluorothreonine 2 in Streptomyces cattleya and Streptomyces sp. MA37,
and FHPA 3 in Streptomyc s sp. MA37.
For decades, Streptomyces cattleya remained the only genetically tractable strain producing two
fluorinated natural products, 1 and 2. The ajor breakthrough was the identification of the first
fluorination enzyme, fluorinase, which converts S-adenosyl-l-methionine (SAM) 6 and fluoride ions to
generate 5′-fluoro-5′-deoxy-adenosine (5′-FDA 7) [6,7]. Subsequent studies resulted in the elucidation
of the biosynthetic pathway of 1 and 2 in S. cattleya as illustrated in Figure 1B [8]. Recent studies
demonstrated that two genes, fthB and fthC, are highly conserved in the biosynthetic gene clusters
(BGCs) that direct the production of 2 [9]. While the genetic inactivation of fthB had no perturbation in
secreted 2 in the S. cattleya variant as observed in 19F-NMR analysis, biochemical analysis indicated that
FthB, an aminoacyl RNA deacylase, plays an essential role in the detoxification of 2, by counteracting
the misacylation of fluorothreonyl-tRNA which otherwise would be misincorporated into protein
in place of L-threonine [9]. While knocking out fthC significantly reduced the concentration of 2 in
culture broth [9], the intracellular 2 was accumulated in the S. cattleya variant, indicating that FthC
is a 4-FT exporter. The efforts towards understanding the fluorination enzyme, fluorometabolisms
in S. cattleya and related biotransformations have offered a new bio-based approach to generating
high-value fluorinated chemicals [10].
In the last decade, advanced geno e sequencing technologies have enabled the use of geno e
ining strategies to identify several other potential fluoro etabolite-producing strains [2,11]. Recent
studies revealed that Streptomyces sp. A37 ( A37), a soil isolate, is a talented natural product
producing strain [12–15]. In particular, 37 produces 1, 2 and a series of unidentified fluorinated
etabolites as observed in 19F-NMR analysis of the supernatant of the culture broth of MA37 [11].
It has been shown that 1 and 2 in MA37 originate from the same biosynthetic pathway as the one
in S. cattleya [11,16]. A combination of chemical synthesis, bioinformatic analysis and biochemical
assays allowed the discovery of 3 as a new fluorometabolite and the identification of the second fdr
biosynthetic gene cluster (BGC) in 37 [2]. o ever, the rest of the fluoro etabolites observed in
37 re ain to be deter ined.
ere we describe the identification of a naturally occurring fluorometabolite,
5-fluoro-5-deoxy-D-ribulose (5-FDRul) 9, from the culture broth of MA37, using a combination
of genetic inactivation, chemo-enzymatic synthesis and 19F-NMR comparison. Although reported
before as chemical probes during the previous fluorometabolism study in S. cattleya, this is the first
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report indicating that 9 is a naturally occurring fluorinated compound. During the course of our studies,
we also observed that the production of several fluorinated natural products was upregulated among
several MA37 fluorometabolite biosynthesis related gene inactivation variants as observed in 19F-NMR
analysis, suggesting that the inactivation of genes responsible for downstream fluorometabolite
biosynthesis may influence metabolic reflux and direct accumulated biosynthetic intermediates to
other previously unnoticed pathways in MA37.
2. Experimental Section
2.1. Fermentation Conditions
E. coli strains were grown in Luria-Bertani (LB) broth (1% tryptone, 0.5% yeast extract, 0.5%
NaCl) or LB agar (1.5% agar) at 37 ◦C, supplemented with the corresponding antibiotics. E. coli
DH10B was used as the routine cloning strain for DNA manipulations. E. coli ET12567 (pUZ8002),
a DNA methylation deficiency stain, served as conjugal donor. MA37 was grown in ISP2 medium
and supplemented with apramycin (20 µM) if needed. For mycelia generation, MA37 was inoculated
from an ISP2 agar palate to YEME liquid medium (50 mL) and harvested after 2 d shake incubation
(180 rpm, 28 ◦C). For fluorometabolite production, MA37 wild type and the confirmed in-frame
deletion variants were grown on ISP2 agar medium for 4 d before being inoculated into ISP2 liquid
medium supplemented with KF (2.5 mM). The seed culture was shake-incubated for 2 d (180 rpm,
28 ◦C). Seed culture (1 mL) was then inoculated into the same ISP2 medium with KF (50 mL) and
shake-incubated for 10–14 d. The supernatant of the culture was obtained by removing the mycelium
with a centrifugation step (4600 rpm, 20 min) and freeze-dried. The crude extract was supplemented
with D2O and subjected to 19F-NMR analysis after 10–14 d fermentation.
2.2. Genomic DNA Isolation
The genomic DNA of MA37 in this study was extracted from 2 mL cell culture. Cell pellet was
harvested after 3 d culture in ISP2 medium by centrifugation and resuspended in 500 µL SET buffer
(100 mM NaCl, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0). The cell suspension was mixed with lysozyme
(4 mg/mL, final concentration) and incubated at 37 ◦C for 30 min. SDS (60 µL, 10% (w/v)) and NaCl
(200 µL, 5 M) were then added to the mixture, followed by further incubation at 60 ◦C for 30 min.
The protein was precipitated with a mixture of phenol, chloroform and isoamylol (500 µL, ratio of
25:24:1) and the resultant mixture was mixed by vortex. The water fraction was obtained after a
centrifugation step and transferred to a new Eppendorf tube with isopropanol for DNA precipitation
(0.8 volumes). The precipitated DNA was washed with 75% (v/v) ethanol, followed by a second wash
with 100% ethanol. The DNA pellet was dried at room temperature and dissolved in sterile MiliQ
water (200 µL).
2.3. The Construction of Plasmids Used for Gene Deletion
To generate the deletion vector for in-frame deletion in MA37, two homologous arms were
amplified by PCR using MA37 genomic DNA as a template (fthCMA left arm forward: ggc cag tgc
caa gct tGG AAT GAA CCC CCA GGA GAC CCG CG, reverse: gcg cag gat acc cgg ACG GTC GGC
CGG CAC TTC GAG GGG; right arm forward: CGG GTG ATC CTG CGC AGG GTC GGG GCG G,
reverse: aca tga tta cga att cTG CCG GAT CCG CAC GGC CAC GGA GC; fthBMA left arm forward: ggc
cag tgc caa gct tCG CGA AGG GCC CGC GTC CGG TAC AC, reverse: cac gga aat cac cga GCC CTA
CCG CTG CCC ATG GTG TTC G; right arm forward: TCG GTG ATT TCC GTG CTC TCC GTG G,
reverse: aca tga tta cga att cTC TCG TTC GCG GTC AGA TGG AGG AC; fdrA left arm forward: ggc cag
tgc caa gct tGC AGG GCG GTG GCG CGT CCG ATG CCG CG, reverse: tcc ccg ttc gcg cag GCA TGT
CCT CGA TCT TGC GT; right arm forward: CTG CGC GAA CGG GGA AAC CCC TTC, reverse: gcg
cgg ccg cgg atc cCG CCA CCG GGC TGA TGG CCC TG; fdrB left arm forward: ggc cag tgc caa gct tTC
TGG TGC CCG ACG GTG ACC GCG AC, reverse: gca atc tca acc acc GCC TGA AGG AAT GGG
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AGG CTC CGC C; right arm forward: GGT GGT TGA GAT TGC ACG GCA T, reverse: gcg cgg ccg
cgg atc cAG CGC GCC CAG TTC GAG AAC CCC). The homologous arms were ligated to the linearized
(HindIII, EcoRI for fthBMA and fthCMA deletion and BamHI, HindIII for the rest) temperature-sensitive
E. coli–Streptomyces shuttle vector pKC1139 via one pot in-fusion cloning (TAKARA) according to the
protocol of the manufacturer (Clontech, TaKaRa, Shiga, Japan). The correct deletion construct was
screened by PCR and confirmed by DNA sequencing.
2.4. The E. coli–Streptomyces Conjugation and Double-Crossover Variant Generation
The confirmed deletion construct was introduced to E. coli ET12567 for the E. coli–Streptomyces
conjugation. As MA37 is bold and produces no spores, mycelia were used for conjugation instead
for spores, and were harvested in YEME culture after 2 d shake incubation. The E. coli donor strain
(2 mL) was harvested and washed with fresh LB medium (3×, 1.5 mL), before being mixed with MA37
mycelia (200 µL) and spread onto an MS agar plate (Mannitol 2%, Soya bean flour 2%, agar 2%, pH 7.5).
The plate was cultured overnight (28 ◦C, 12–16 h) and overlaid with apramycin and nalidixic acid
(50 µM, final concentration). The exoconjugates were purified and single-crossover variants were
isolated by incubation at 37 ◦C to promote plasmid loss. Double-crossover mutant was then acquired
by multiple steps of subculture onto an antibiotic-free ISP2 agar plate and confirmed by PCR screening
and genomic DNA sequencing.
2.5. The Synthesis of 5-FDR
The 5-fluoro-5-deoxy-D-ribose (5-FDR) 8 synthesis protocol was taken from the literature [17,18].
D-(-)-ribose 14 (1.5 g, 1 eq) was added to a round-bottom flask (250 mL) with acetone (80 mL) and cooled
under an ice bath. Then, 2,2-dimethoxypropane (2.6 g, 2.5 eq) was added into the mixture. Perchloric
acid was added dropwise into the mixture for 5 min. The ice bath was removed and the reaction
mixture stirred at room temperature overnight. The reaction mixture turned orange the next morning.
Methanol (2.02 mL, 5 eq) was added into the mixture and it was stirred for 3 h. The reaction was
quenched by the saturated addition of sodium hydrogen carbonate. The suspension was filtered and
rotary evaporated to minimum volume (aqueous phase). The aqueous phase was extracted by ethyl
acetate (3 × 100 mL, organic phase). The combined organic phase was dried by anhydrous magnesium
sulphate, filtered and dried under vacuum. Then, 1-methoxy-2,2-isopropyliden-α/β-D-ribofuranose
15 (1 g, 1 equiv) was oven-dried and placed under an argon atmosphere system. Dry pyridine (3 mL)
was added into the system and the mixture was cooled under an ice bath. After 5 min, p-toluenesulfonyl
chloride (1.5 equiv) was added into the mixture, which was stirred under the ice bath for 2 h. When
the reaction completed, the mixture was poured into 5 mL of ice-cold water with vigorous stirring,
and the precipitate formed. The precipitate was filtered, washed by ice-cold water (5 × 5 mL) and
dried under a freeze drier. Then, 2,3-O-isopropylidene-5-O-(p-toluenesulfonyl)-β,D-ribofuranoside
16 (600 mg, 1.68 mmol, 1 equiv) was added into a flame-dried round-bottom flask and connected
to the reflux system. The argon cycle was applied to the system. Anhydrous acetonitrile (7 mL)
was added, followed by tetra-n-butylammonium fluoride (TBAF) (2 mL). The system was heated to
80 ◦C under reflux overnight. The reaction mixture was dried under vacuum the following morning.
The dried product was purified by a silica gel column (mobile phase: petroleum ether:ethyl acetate
10:1). Aqueous sulphuric acid (0.2 M) was mixed into the purified product and heated overnight.
The reaction mixture was cooled to room temperature the following morning and neutralized by
barium carbonate. The suspension was centrifuged and the supernatant was freeze-dried.
2.6. The Generation of 5-FDRul
For the preparation of 5-FDRul 9, the synthesized 5-FDR 8 (1 mM) was incubated with immobilized
glucose isomerase (30 mg) in KH2PO4 buffer (50 mM, pH 6.8) at 37 ◦C for 6 h. The enzyme was
removed from the reaction mixture by centrifuge (13,000× g, 10 min). The supernatant was subjected
to 19F-NMR analysis.
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3. Results and Discussion
Considering that MA37 produces a broader spectrum of fluorometabolites compared to S. cattleya,
the gene homologues of fthB and fthC in MA37 (fthBMA and fthCMA, respectively) may have roles in
other unidentified fluorometabolites. To this end, we generated two MA37 variants where fthBMA
and fthCMA were subjected to in-frame deletion, respectively. After fermentation (50 mL, 28 ◦C, 12 d),
the supernatants of the culture broths of the two variants along with the wild type (WT) were subjected
to 19F-NMR analysis. The MA37_∆fthBMA variant demonstrated a relatively similar pattern of secreted
2 as well as other unidentified fluorometabolite production to the WT, consistent with the previous
conclusion for S. cattleya [9] (Figure 2A,B).
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(D). The asterisks indicate three unidentified fluorometabolites with increased production
in MA37_∆fthBMA.
Gene inactivation of fthCMA, which encodes a putative 4-FT exporter, led to significant reduction
of 2 as observed in 19F-NMR analysis, also consistent with the previous report [9]. We noticed that
1 together with five other unknown fluorometabolites (compounds with star labels and 5-FDR 8, 9
(Figure 2D)) showed increased production in the MA37_∆fthCMA variant compared to the ones in
the WT (Figure 2A,C and Figure S1). The accumulation of these unidentified fluorometabolites in the
MA37_∆fthCMA variant suggested that they are shunt metabolites, arising from aberrant derailment
of the main pathways of 1 and 2 in MA37.
Next, we investigated the effect of the biosynthetic genes in the fdr BGC on other fluorometabolites,
which contain three functionally assigned proteins in the pathway of 3 [2]. FdrA was proposed to be a
metal-dependent phosphoesterase that mediates the dephosphorylation of 5-FDRP 11 to generate 8,
the key intermediate in the second biosynthetic pathway leading to the production of 3 [2]. FdrC has
been biochemically characterized to be a short-chain dehydrogenase that catalyzes the oxidation of
5-FDR 8, followed by spontaneous hydrolysis to yield 3. FdrB is a putative dihydroxyacid dehydratase,
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an enzyme analogue of SalH in the biosynthesis of salinosporamide A [19], which has been proposed
to convert 5-chlororibonate to 5-chloro-4-hydroxy-2-oxopentanoate (Figure S2).
To this end, we generated two MA37 variants, ∆fdrA and ∆fdrB. Comparative fluorometabolite
profiling observed in the 19F-NMR analysis revealed that the production of 3 in these two variants
was reduced compared to in the WT (Figure 3) while 1 and 2 were only mildly affected. Interestingly,
the inactivation of individual genes indeed affected other unidentified fluorometabolites. One of
the fluorine signals with a significantly different intensity is found at −227.80 ppm (compound
13 in Figure 3C,D). The production of this metabolite was abolished in ∆fdrA and ∆fdrB variants
compared with the one in the WT, suggesting that the production of this metabolite is directly
related to the catalytic functions of FdrA and FdrB. One possibility is that this metabolite is
5-fluoro-4-hydroxy-2-oxopentanoate 13, a dehydrated product generated by the action of FdrB
on 3.
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Figure 3. The 19F-NMR analysis of fluorometabolites from the MA37 WT full fluorometabolite spectrum
(A), and the comparison of MA37 WT (B), MA37_∆fdrA (C) and MA37_∆fdrB (D).
Another significant fluctuation in the 19F-NMR spectra is the signal at −231.42 ppm (compound
9 in Figure 3). While the production level of this metabolite appears to be reduced in the ∆fdrB
variant compared to the WT (Figure 3A,B), the inactivation of fdrA upregulated the production of
this metabolite as observed in Figure 3C. Interestingly, this fluorometabolite was also accumulated in
the ∆fthCMA MA37 variant, suggesting that the synthesis of this fluorometabolite may result from
the common intermediates in the biosynthetic pathways of 1, 2 and 3. However, the biochemical
characterization of the enzymes produced by the genes fdrA and fdrB was not successful due to
production problems in E. coli (inclusion bodies). Based on previous studies in S. cattleya, the chemical
shift of this metabolite in 19F-NMR spectrum highly coincided with that of 5-FDRul 9 [17]. Previously,
9 was synthesized to probe the fluorometabolism in S. cattleya, and it was found that it is not one
of the intermediates or a metabolite in the culture of S. cattleya. To confirm whether 9 was indeed
a metabolite in MA37, the compound was prepared synthetically according to the protocols in the
literature [17]. Moreover, 8 was first chemically prepared from D-ribose according to the literature
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(Figure 4A and Figures S3–S7) [18], followed by enzymatic conversion to 5-FDRul using commercially
available glucose isomerase (Sigma Aldrich UK cat no. G4166). The inspection of 19F-NMR indicated
that 9 (−231.42 ppm observed in 19F-NMR) (Figure 4C and Figures S8 and S9) was indeed generated in
a mixture of unreacted α- and β- anomers of 8 (−227.80 and −231.42 ppm, respectively) compared with
the synthetic 5-FDR sample (Figure 4B). The 19F-NMR signals coincided when the enzyme reaction
sample was mixed with the supernatant of MA37 fermentation broth (Figure 4E), confirming that
the fluorine signal at −231.42 ppm is 9. Interestingly, the chemical shifts of both anomers of 8 in the
reaction mixture also overlapped with two previously unknown signals in the supernatant of MA37
culture broth as evidenced in the 19F-NMR spectra (Figure 4B,E). Taken together, this study identified
9 as one of the unidentified fluorometabolites in MA37, further extending the very small collection of
this rare class of bacterial natural products.
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Figure 4. The identification of 5-fluoro-5-deoxy-D-ribulose (5-FDRul) in the fluorometabolite spectrum
of MA37. (A). The scheme describing the synthesis route using D-(-)-ribose to generate 5-FDRul 9.
(B). The synthesis product of 5-FDR. (C). The reaction mixture of 5-FDR 8 after incubation with glucose
isomerase. (D). The aqueous extraction of MA37 wild type fluorometabolites. (E). The spiking of (C)
into (D). The synthetic 5-FDRul merged with the peak at −231.42 ppm from MA37 wild-type aqueous
extract, confirming it to be one of the fluorometabolites observed from the spectru .
Additionally, 8 was proposed to be a key intermediate in the branched fluorometabolism
for generating FHPA as a result of the action of FdrA, a metal-dependent phosphoesterase [2].
The increased accumulation of 8 in the MA37 variants ∆fdrA and ∆fthCMA suggested that another
promiscuous house-keeping enzyme in MA37 is able to generate 8. One possible enzyme candidate is
5′-methylthioadenosine (MTA) nucleosidase, a key enzyme, in the methionine salvage pathway in
microbes, that catalyzes 5′-methylthioadenosine to its corresponding methylthioribose (Figure 5) [20].
Interestingly, it is likely that S. cattleya may recruit 5-methylthio-ribose-1-phosphate isomerase, another
key enzyme in the methionine salvage pathway, as part of its fluorometabolism toward 1 and 2
(Figure S10) [8]. This indicated that natural product biosynthetic pathways can recruit promiscuous
enzymes from primary metabolisms to enable the evolution of biosynthetic capacity and expand the
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range of known organofluorine biochemistry. A BLAST search using the sequence of MTA nucleosidase
from Streptomyces laurentii (accession no. BAU88196) as a query against the annotated MA37 draft
genome in the RAST server [21] revealed the presence of one gene encoding MTA nucleosidase in MA37
(accession no. MT478135). The encoded protein possesses several crucial amino acids for substrate
binding and catalytic function as displayed by multiple sequence alignment. Protein modelling in
the Pyre2 server [22] also indicated that the overall predicted structure shares high homologue (100%
confidence) with other MTA nucleosidases and purine nucleoside hydrolases (Figure S11). This
analysis is in sharp contrast to what has been observed in S. cattleya and S. xinghaiensis. No such
gene encoding MTA nucleosidase can be found in the genomes of either S. cattleya or S. xinghaiensis.
It is known that S. cattleya is the producer of 1 and 2 [23] and that S. xinghaiensis only produces
1 [23]. In both cases, no other fluorometabolites were found in these bacteria. Our bioinformatics
analysis strongly suggests that the putative MTA nucleosidase in MA37 is responsible for the increased
accumulation of 8. MTA nucleosidases catalyze a similar biochemical reaction to that of the purine
nucleoside hydrolase identified in the purine salvage pathway that catalyzes adenosine to D-ribose.
Previously, a purine nucleoside hydrolase from Trypanosoma vivax (TvNH) was shown to mediate
the conversion of 5′-FDA to 5-FDR. As a result, it has been utilized as a biocatalyst in one-pot
biotransformation involving fluorinase for the synthesis of 5-deoxy-5-[18F] fluororibose as a potential
diagnostic reagent for positron emission tomography applications [24]. MTA nucleosidase from E. coli
has been shown to be able to convert adenosine to D-ribose, albeit less efficiently than its natural
substrate, 5′-methylthioadenosine [25]. Therefore, the putative MTA nucleosidase in MA37 is likely to
be responsible for the accumulation of 8 in the MA37 variants. The biochemical characterization of this
protein may offer an alternative biocatalyst to the biotransformation of 5-deoxy-5-[18F] fluororibose.
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Figure 5. The proposed pathways of identified fluorometabolites in Streptomyces sp. MA37. Arrows
with solid lines indicate the enzymatic reactions were biochemically confirmed. Arrows with dashed
lines indicate biotransformations that remain to be determined. The compounds in boxes are new
fluorometabolites identified in this study.
The bio-origin of 9 still remains to be biochemically determined. It is worth noting that, although
9 has been synthesized as a chemical probe, 9 is not part of the fluorometabolism in S. cattleya [17].
In the case of MA37, 9 is likely to be a shunt product deviating from the two main fluorometabolisms,
resulting from the premature isomerization or hydrolysis of reactive intermediates, such as 8 or 12,
respectively (Figure 5). No gene encoding glucose isomerase was found in the draft genome of MA37.
Although ribose isomerase, which has been shown to catalyze the conversion of D-ribose to D-ribulose,
was purified from extracts of mycobacterium smegatis in 1975 [26], its protein sequence remains to be
confirmed. One may not exclude the possibility that a homologue of ribose isomerase present in MA37
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is responsible for the production of compound 9 in MA37 WT and its variants. Another possibility is
that the presence of 9 may result from a promiscuous dephosphorylase enzyme that directly converts
12 to 9.
4. Conclusions
In this study, 9 was found to be the shunt fluorometabolite in MA37 using a combination
of genetic inactivation, chemo-enzymatic synthesis and NMR analysis. The inactivation of key
biosynthetic genes in both the fl and fdr gene clusters in MA37 resulted in the divergent production
of other unidentified fluorometabolites as observed in 19F-NMR analysis. The identification of
these two new fluorometabolites in MA37 expands the scope of bacteria-derived fluorometabolites,
suggesting the existence of other gene products that are able to metabolize intermediates in the known
fluorometabolisms in MA37. Compound 9 is a mono-fluorine-substituted sugar derivative which
may serve as an important building block in other chemical and biochemical investigations [27].
Understanding the biochemistry of these metabolites will facilitate the synthesis of fluorinated building
blocks through de novo biotransformation from fluoride ions.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/10/7/1023/s1,
Figure S1: 19F-NMR analysis of FAc 1 from MA37 WT (A), MA37_∆fthBMA (B) and MA37_∆fthCMA (C)., Figure S2:
The comparison of the fdr pathway (A) and the precursor biosynthesis pathway sal of salinosporamide A (B), Figure
S3: 1H-NMR of 1-methoxy-2,2-isopropyliden-α/β-D-ribofuranose 15 (400MHz, CD3OD), Figure S4: 1H-NMR of
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8 (400MHz, D2O), Figure S8: Decoupling 19F-NMR of generation of 5-FDRul 9 (400MHz, D2O), Figure S9: The
coupling 19F-NMR spectrum of 5-FDR 8, Figure S10: A. The biochemical reaction of MTA nucleosidase in primary
metabolism. B. The putative recruitment of 5-methylthio-ribose-1-phosphate isomerase from methionine salvage
pathway as part of Streptomyces cattleya’s fluorometabolism. C. The proposed incorporation of MTA nucleosidase
in 3 biosynthesis in MA37, Figure S11, The comparison of the predicted structure of MTA nucleosidase from MA37
(A) with the one from Campylobacter jejuni (B) (PDB No. 6AYT), suggesting the high degree of similarity of their
overall structures and the highly conserved catalytic dyad (Ser 162-Asp-163 in the case of MTA nucleosidase from
MA37) and the substrate binding pocket (Met139-Glu140). C. The multiple amino acid sequences alignment of
the MTA nucleosidase found in MA37 with several other well-characterized MTA nucleosidase, showing the
conserved catalytic dyad (Ser 162-Asp-163) and substrate binding pocket (Met139-Glu140).
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